Chun-Min Wang

Chun-Min Wang

Auto-generated profile, based on publicly available information

Chun-Min Wang

Department of Neurology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CWChun-Min Wang
Chun-Min Wang
YCYu-Ming Chang
Yu-Ming Chang
PSPi-Shan Sung
Pi-Shan Sung
CCChih-Hung Chen
Chih-Hung Chen
Background: This study was to evaluate the correlation of the hypoperfusion intensity ratio (HIR) with the collateral score from multiphase computed tomography angiography (mCTA) among patients with large vessel stroke. Method: From February 2019 to May 2020, we retrospectively reviewed the patients with large vessel strokes (intracranial carotid artery or proximal middle cerebral artery occlusion). HIR was defined as a Tmax > 10 s lesion volume divided by a Tmax > 6 s lesion volume, which was calculated by automatic software (Syngo.via, Siemens). The correlation between the HIR and mCTA score was evaluated by Pearson’s correlation. The cutoff value predicting the mCTA score was evaluated by receiver operating characteristic analysis. Result: Ninety-four patients were enrolled in the final analysis. The patients with good collaterals had a smaller core volume (37.3 ± 24.7 vs. 116.5 ± 70 mL, p < 0.001) and lower HIR (0.51 ± 0.2 vs. 0.73 ± 0.13, p < 0.001) than those with poor collaterals. A higher HIR was correlated with a poorer collateral score by Pearson’s correlation. (r = −0.64, p < 0.001). The receiver operating characteristic (ROC) analysis suggested that the best HIR value for predicting a good collateral score was 0.68 (area under curve: 0.82). Conclusion: HIR is a good surrogate of collateral circulation in patients with acute large artery occlusion.

5 December 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
MHMeng-Tsang Hsieh
Meng-Tsang Hsieh
CCChih-Hung Chen
Chih-Hung Chen
SLSheng-Hsiang Lin
Sheng-Hsiang Lin
PLPo-Yu Lin
Po-Yu Lin
YCYu‐Ming Chang
Yu‐Ming Chang
PSPi-Shan Sung
Pi-Shan Sung
Background: An increased risk of recurrent stroke is noted in patients with atrial fibrillation despite direct oral anticoagulant (DOAC) use. We investigated the efficacy and safety of treatment with each of 4 different DOACs or warfarin after DOAC failure. Methods and Results: We retrospectively analyzed patients with atrial fibrillation with ischemic stroke despite DOAC treatment between January 2002 and December 2016. The different outcomes of patients with DOAC failure were compared, including recurrent ischemic stroke, major cardiovascular events, intracranial hemorrhage and subarachnoid hemorrhage, mortality, and net composite outcomes according to switching to different DOACs or vitamin K antagonist after index ischemic stroke. We identified 3759 patients with DOAC failure. A total of 84 patients experienced recurrent ischemic stroke after switching to different oral anticoagulants, with a total follow‐up time of 14 years. Using the vitamin K antagonist group as a reference, switching to any of the 4 DOACs was associated with a 69% to 77% reduced risk of major cardiovascular events (adjusted hazard ratio [aHR], 0.25 [95% CI, 0.16–0.39] for apixaban, 0.23 [95% CI, 0.14–0.37] for dabigatran, 0.23 [95% CI, 0.09–0.60] for edoxaban, and 0.31 [95% CI, 0.21–0.45] for rivaroxaban), and a 69% to 83% reduced risk of net composite outcomes (aHR, 0.25 [95% CI, 0.18–0.35] for apixaban, 0.17 [95% CI, 0.11–0.25] for dabigatran, 0.31 [95% CI, 0.17–0.56] for edoxaban, and 0.31 [95% CI, 0.23–0.41] for rivaroxaban). Conclusions: In Asian patients with DOAC failure, continuing DOACs after index stroke was associated with fewer undesirable outcomes than switching to a vitamin K antagonist. Alternative pharmacologic and nonpharmacologic strategies warrant investigation.

1 April 2023 in Stroke
Verified
Journal Article
Closed access
MHMeng-Tsang Hsieh
Meng-Tsang Hsieh
CCChih-Hung Chen
Chih-Hung Chen
SLSheng-Hsiang Lin
Sheng-Hsiang Lin
PLPo-Yu Lin
Po-Yu Lin
YCYu-Ming Chang
Yu-Ming Chang
PSPi-Shan Sung
Pi-Shan Sung

15 February 2024 in Journal of the Formosan Medical Association
Verified
Journal Article
Open access
CWChun-Min Wang
Chun-Min Wang
YCYu-Ming Chang
Yu-Ming Chang
RTRay-Chang Tzeng
Ray-Chang Tzeng
TCTsang-Shan Chen
Tsang-Shan Chen
SWShang-Te Wu
Shang-Te Wu
PSPi-Shan Sung
Pi-Shan Sung
Endovascular thrombectomy (EVT) is a time-sensitive treatment for acute ischemic stroke with large vessel occlusion. To optimize transfer efficiency, a web-based platform was introduced in the Tainan Stroke Network (TSN). We assessed its application and effectiveness in regional stroke care. This new web-based platform containing a questionnaire-style interface was introduced on October 1, 2021. To assess the transfer efficiency and patient outcomes, acute stroke patients transferred from PSCs to CSC for EVT from April 01, 2020, to December 30, 2022, were enrolled. The patients were classified into the traditional transferal pathway (TTP) group and the new transferal pathway (NTP) group depending on mode of transfer. Patient characteristics, time segments after stroke onset and outcome were compared between groups. A total of 104 patients were enrolled, with 77 in the TTP group and 27 in the NTP group. Compared to the TTP group, the NTP group had a significantly shorter onset-to-CSC door time (TTP vs. NTP: 267 vs. 198 min; p = 0.041) and a higher EVT rate (TTP vs. NTP: 18.2% vs. 48.1%, p = 0.002). Among EVT patients, those in the NTP group had a significantly shorter CSC door-to-puncture time (TTP vs. NTP: 131.5 vs. 110 min; p = 0.029). The NTP group had a higher rate of good functional outcomes at 3 months (TTP vs. NTP: 21% vs. 61.5%; p = 0.034). This new web-based EVT transfer system provides notable improvements in clinical outcomes, transfer efficiency, and EVT execution for potential EVT candidates without markedly changing the regional stroke care paradigm.

1 November 2010 in Biology of Reproduction
Verified
Journal Article
Open access
KLKiho Lee
Kiho Lee
CWChunmin Wang
Chunmin Wang
JCJohn M. Chaille
John M. Chaille
ZMZoltan Machaty
Zoltan Machaty
The oscillation in the intracellular free Ca2+ and the depletion of the intracellular stores stimulates an influx of extracellular Ca2+. This Ca2+ influx is responsible for sustaining the long-lasting Ca2+ oscillation. A previous report from our lab indicates that STIM1, a known Ca2+ sensor in somatic cells is expressed in porcine oocytes and is essential for store-operated Ca2+ entry. Because a Ca2+ entry through the plasma membrane is critical for the maintenance of Ca2+ oscillation during fertilization, we hypothesized that STIM1 function has implications for subsequent embryo development. In this study, the inactivation of STIM1 in oocytes and its effect on early embryo development after fertilization was investigated using the pig as a model. Gilt ovaries were obtained at a local abattoir and immature oocytes were collected by aspirating mid-size follicles. The oocytes were matured in vitro in a TCM199-based medium. First, matured oocytes (34 hours after the beginning of maturation) were denuded, allocated into three groups and injected with either physiological saline (control), non-functional control siRNA, or siRNA against STIM1. Approximately 10 h later, injected oocytes were fertilized and cultured in Porcine Zygote Medium 3 (PZM-3) for 7 days. Frequencies of cleaved embryos and blastocyst formation were recorded and analyzed by ANOVA following with acrsin transformation. For the second experiment, oocytes were fertilized at 42-44 hours after the beginning of maturation, and then injected with saline or siRNA against STIM1 at 5 hours post fertilization. These embryos were also cultured for 7 days and the frequency of cleaved embryos was compared by chi-square analysis. Down regulation of STIM1 prior to fertilization was detrimental to embryo development. Frequencies of cleaved embryos after injections with saline, control siRNA, and siRNA against STIM1 were 67.8%, 72.5%, and 25.8%, respectively. Cleavage frequency in embryos injected with STIM1 siRNA was lower compared to that of the other groups (p<0.01). Similar tendencies were observed in blastocyst formation. Only 0.8% of embryos formed blastocyst after STIM1 siRNA injection, whereas blastocyst formation in the saline- and control siRNA-injected groups were 14.9% and 14.2%, respectively (p<0.01). When siRNA against STIM1 was delivered into oocytes 5 hours after fertilization, embryo cleavage was not affected: the proportions of 2-cell embryos after injection of saline or STIM1 siRNA were 66.0% and 72.9%, respectively. Our results indicate that STIM1 plays a critical role during fertilization and normal STIM1 function has an effect on subsequent embryo development. The fact that the absence of STIM1 affects embryo development only when inactivation takes place prior to fertilization indicates that STIM1 is essential during fertilization. On the other hand, STIM1 inactivation 5 h post fertilization had no detrimental effect on embryo development. These findings support our hypothesis that STIM1 is involved in the maintenance of Ca2+ oscillation during fertilization. The exact role of STIM1 in Ca2+ signaling during fertilization is under investigation. (platform)

2 June 2026 in medRxiv
Verified
Preprint
Open access
PDF file
PTPo-Yu Tsai
Po-Yu Tsai
CLChe-Wei Lin
Che-Wei Lin
YCYu-Ming Chang
Yu-Ming Chang
RTRay-Chang Tzeng
Ray-Chang Tzeng
MWMing-Hsiu Wu
Ming-Hsiu Wu
PSPi-Shan Sung
Pi-Shan Sung
Background and Purpose: Futile interhospital transfers, where patients transferred for endovascular thrombectomy (EVT) do not ultimately receive the procedure, represent a critical systemic burden on stroke transfer network. Whether pre-transfer computed tomography angiography (CTA) at the primary stroke center (PSC) reduces futile transfers, and at what workflow cost, remains incompletely characterized. Methods: This retrospective study enrolled 314 acute ischemic stroke patients transferred for potential EVT within the Tainan-Chiayi Stroke Network (October 2021–September 2025). Patients were stratified by CTA timing: pre-transfer (n=66) versus post-transfer (n=248). Workflow time metrics and 90-day functional outcomes were compared. Futile transfers were classified into three categories: preventable over-triage, physiological futility, and gray zone cases. Results: The futile transfer rate was substantially lower in the pre-transfer CTA group (27.3% vs. 66.1%; P<0.001), with post-transfer CTA as the strongest independent predictor of futility (aOR 5.21; 95% CI 2.83–9.60). In the post-transfer CTA group, 40.2% of futile transfers involved conditions identifiable by pre-transfer CTA. Regardless of CTA timing, gray zone cases predominated in both groups (83.3% vs. 47.6%), driven by intracranial atherosclerotic stenosis/ chronic total occlusion, large infarct cores, and medium vessel occlusions. Pre-transfer CTA significantly prolonged PSC door-in-door-out time (140 vs. 88 min; P<0.001) and showed numerical trends toward longer onset-to-EVT time and lower rates of favorable functional outcome. Conclusions: Adopting CTA during the pre-transfer period reduces preventable futile transfers but prolongs PSC processing time. Nevertheless, the persistent gray zone requires strategies beyond imaging alone, and the trade-off between triage precision and transfer efficiency warrants ongoing evaluation across different stroke networks settings.